Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_provenance.
- NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_assertion wasGeneratedBy ECO_0000203 NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_provenance.
- NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_assertion wasDerivedFrom befree-20140225 NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_provenance.
- NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_assertion SIO_000772 21607772 NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_provenance.
- NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_assertion evidence source_evidence_literature NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_provenance.
- NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_assertion description "[In survival after tumor recurrence, the EGFR group had a better median survival time (46.7 months) after recurrence than the KRAS group (26.0 months).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_provenance.
- befree-20140225 importedOn "2014-02-25" NP258413.RAU-Br7_70Xgbaf6Rl0_9cC2rcpzFoeXQNK3QZywY6Z4Q130_provenance.